Karjula, Topias http://orcid.org/0000-0002-2342-6034
Niskakangas, Anne
Mustonen, Olli
Puro, Iiris
Elomaa, Hanna
Ahtiainen, Maarit
Kuopio, Teijo
Mecklin, Jukka-Pekka
Seppälä, Toni T.
Wirta, Erkki-Ville
Sihvo, Eero
Yannopoulos, Fredrik
Helminen, Olli
Väyrynen, Juha P.
Funding for this research was provided by:
Instrumentariumin Tiedesäätiö
Mary och Georg C. Ehrnrooths Stiftelse
Syöpäsäätiö
Jane ja Aatos Erkon Säätiö
University of Oulu including Oulu University Hospital
Article History
Received: 1 March 2023
Revised: 8 May 2023
Accepted: 5 June 2023
First Online: 20 June 2023
Declarations
:
: The Oulu University Hospital Ethics Committee (EETMK 81/2008) approved the study. The Finnish National Authority of Medicolegal Affairs (VALVIRA) waived the need for informed consent due to the retrospective nature of the study. The study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: TTS reports consultation fees from Amgen Finland, and being a co-owner and CEO of Healthfund Finland. The other authors declare no conflicts of interest.